Your browser is no longer supported. Please, upgrade your browser.
We’ve released a new Beta version of our Futures section! Try it now. We look forward to your feedback! ×
Settings
JNJ [NYSE]
Johnson & Johnson
IndexDJIA S&P500 P/E18.08 EPS (ttm)5.59 Insider Own0.01% Shs Outstand2.78B Perf Week1.51%
Market Cap281.06B Forward P/E15.68 EPS next Y6.45 Insider Trans-29.76% Shs Float2.78B Perf Month0.74%
Income15.92B PEG3.53 EPS next Q1.70 Inst Own67.40% Short Float1.07% Perf Quarter-0.40%
Sales73.59B P/S3.82 EPS this Y18.50% Inst Trans-0.02% Short Ratio3.40 Perf Half Y1.22%
Book/sh24.68 P/B4.10 EPS next Y4.97% ROA15.50% Target Price109.10 Perf Year3.90%
Cash/sh11.90 P/C8.49 EPS next 5Y5.13% ROE27.40% 52W Range93.83 - 108.23 Perf YTD-2.66%
Dividend2.80 P/FCF- EPS past 5Y5.30% ROI18.40% 52W High-6.61% Beta0.58
Dividend %2.77% Quick Ratio2.00 Sales past 5Y3.70% Gross Margin69.30% 52W Low7.73% ATR1.22
Employees126500 Current Ratio2.40 Sales Q/Q-4.10% Oper. Margin30.10% RSI (14)52.97 Volatility0.99% 1.11%
OptionableYes Debt/Eq0.27 EPS Q/Q-6.70% Profit Margin28.10% Rel Volume0.75 Prev Close100.46
ShortableYes LT Debt/Eq0.22 EarningsApr 14 BMO Payout38.20% Avg Volume8.78M Price101.08
Recom2.50 SMA200.74% SMA500.50% SMA200-1.20% Volume6,543,724 Change0.62%
Dec-08-14Reiterated RBC Capital Mkts Outperform $110 → $114
Jul-16-14Reiterated Deutsche Bank Hold $102 → $107
Apr-17-14Reiterated Argus Buy $104 → $116
Apr-16-14Reiterated RBC Capital Mkts Outperform $104 → $106
Jan-10-14Downgrade Barclays Overweight → Equal Weight $99
Jan-07-14Upgrade RBC Capital Mkts Sector Perform → Outperform $88 → $104
Dec-16-13Reiterated Deutsche Bank Hold $93 → $95
Jul-18-13Reiterated Argus Buy $96 → $104
Jul-17-13Reiterated Barclays Overweight $95 → $99
Jul-17-13Downgrade Deutsche Bank Buy → Hold $92 → $93
Apr-18-13Reiterated Argus Buy $80 → $96
Apr-15-13Reiterated Barclays Overweight $85 → $95
Apr-12-13Reiterated Deutsche Bank Buy $82 → $87
Mar-26-13Reiterated UBS Buy $81 → $87
Jan-11-13Reiterated UBS Buy $76 → $78
Jan-04-13Upgrade Deutsche Bank Hold → Buy $75 → $82
Nov-20-12Initiated Stifel Nicolaus Hold
Jul-18-12Reiterated RBC Capital Mkts Sector Perform $65 → $71
Apr-18-12Reiterated UBS Buy $71 → $70
Dec-12-11Reiterated UBS Buy $72 → $69
Apr-25-15 09:05AM  4 Dividends and Buybacks That Should Not Be Ignored at 24/7 Wall St.
Apr-24-15 09:46PM  J&J and DuPont Lead the Payout Parade at Barrons.com
04:42PM  Abbott Laboratories (ABT) Earnings Analysis: By the Numbers
04:06PM  A Stronger Dollar Hurts the Performance of Large-Cap Stocks
04:01PM  The 4 Stocks That Dominated the DJIA on Friday at 24/7 Wall St.
03:16PM  Eli Lilly (LLY) Earnings Analysis: By the Numbers
02:45PM  Johnson & Johnsons Revenues Take a Hit with Stronger Dollar
02:44PM  Johnson & Johnson Posts Earnings, Lowers EPS Guidance on April 14
11:03AM  The 10 global companies that get diversity: Study at CNBC
10:27AM  JOHNSON & JOHNSON Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Other Events, Financial St
Apr-23-15 07:14PM  Big Medical Device Makers Form Their First Industry Trade Group in Asia at The Wall Street Journal
07:07PM  Merck Gets a Boost of 69% in AQR Capitals Portfolio
06:11PM  Strong dollar squeezes company earnings AP
04:16PM  DepoMed Set To Grow On 'Transformative' Nucynta Deal at Investor's Business Daily
03:06PM  Johnson & Johnson hikes quarterly dividend 7 percent
02:13PM  How Jay Z Caused Tidal's Hard Knock Life
12:22PM  Technician Breaks Down Johnson & Johnson
12:11PM  Johnson & Johnson Lifts Dividend at The Wall Street Journal
12:06PM  AQR Capital Enhances Pfizer Holdings by 33%
11:55AM  After Dividend Hike at J&J, Investors Can Expect Many Years of More Hikes at 24/7 Wall St.
11:29AM  Johnson & Johnson Announces Dividend Increase of 7.1% at noodls
10:59AM  Johnson & Johnson Announces Dividend Increase of 7.1% PR Newswire
10:45AM  Abbvie's CEO Gonzalez: We're Now In Pharma's 'Top Tier' at Forbes
09:47AM  AbbVie raises guidance after 1Q sales beat
12:37AM  [$$] Blackstone Is Giving New Moms More Time Off at The Wall Street Journal
Apr-22-15 11:51PM  Blackstone Is Giving New Moms More Time Off at The Wall Street Journal
04:45PM  15 'Sustainable' Companies Not Named Apple to Buy Right Now at TheStreet
01:50PM  How a Stronger US Dollar Has Affected Large-Cap Stocks
11:11AM  Q1 2015 Earnings and Why I Like JNJ, STX And WFC at Forbes
10:43AM  Economic Releases and Corporate Earnings Direct Market Movement
09:35AM  Teva-Mylan-Perrigo: Merger Mania In Pursuit Of Generic Margins at Forbes
09:30AM  The Zacks Analyst Blog Highlights: Gilead Sciences, Biogen, Geron, Johnson & Johnson and Anthera Pharmaceuticals - Press Releases
Apr-21-15 05:54PM  Pharmacyclics Announces Positive Results on Imbruvica - Analyst Blog
04:45PM  Mixed earnings news leaves US stocks mostly lower
09:09AM  Forget Gilead (GILD), Buy These Impressive Biotech Stocks Instead - Analyst Blog
07:20AM  St. Louis companies among the 'best corporate citizens' at bizjournals.com
Apr-20-15 06:36PM  IBM Earnings Continue To Reflect Transition Challenge at Investor's Business Daily
06:07PM  AQR Capital Ups Stake in Johnson and Johnson
04:08PM  MylanPerrigo Merger: What Are the Long-Term Growth Drivers?
03:44PM  Johnson & Johnson to Host Pharmaceutical Business Review at noodls
02:58PM  Will Amgen (AMGN) Keep Earnings Streak Alive in 1Q? - Analyst Blog
02:20PM  Johnson & Johnson to Host Pharmaceutical Business Review PR Newswire
09:30AM  The Zacks Analyst Blog Highlights: Goldman Sachs Group, Intel, Johnson & Johnson, JPMorgan Chase and UnitedHealth Group - Press Releases
Apr-18-15 08:02AM  IBM Transition In Focus With Q1 Earnings at Investor's Business Daily
Apr-17-15 08:04PM  Hottest ETF Strategy: Factor Investing In Stocks at Investor's Business Daily
05:26PM  Johnson & Johnson's New Billion-Dollar Blockbuster at Investopedia
02:27PM  7 Dow Stocks Beat Earnings Estimates But Shares Slide Anyway at Forbes
11:02AM  Dow 30 Stock Roundup: GE Plans Restructuring, JPM, Goldman, UNH Beat Estimates - Analyst Blog
10:09AM  Maverick Capital Increases Stake in Novartis
09:40AM  Weight Watchers (WTW) Horrid Q1 Not Enough to Stop North Tide Capital From Double Digit Returns at Insider Monkey
03:05AM  Heres what CEOs said about the economy this week
Apr-16-15 04:01PM  The 4 Stocks That Weighed on the DJIA Thursday at 24/7 Wall St.
10:50AM  Receptos MS Drug Succeeds Against Ulcerative Colitis at Investor's Business Daily
10:05AM  5 Must-See Stock Charts to Trade for Gains at TheStreet
08:30AM  Healthcare ETFs in Focus Post JNJ Earnings Beat - ETF News And Commentary
Apr-15-15 07:51PM  Contact lens makers sue Utah over anti-price fixing law
07:16PM  Are J&J's Results a Harbinger of Things to Come? at Investopedia
06:16PM  Robots In Our Homes And In Our Personal Lives at Forbes
05:43PM  4 ways a surging dollar rattles world economies, markets AP
04:21PM  J&J Earnings Analysis: By the Numbers
03:43PM  Bank Of America Sees Big Divestitures Upcoming For Johnson & Johnson
01:57PM  Biotech IPOs Ignite As Aduro Doubles On First Day at Investor's Business Daily
01:56PM  TechBits: Analyzing medical data, breaking smartphones
01:33PM  AQR Capital Trades Key Positions in its 4Q14 Portfolio
12:15PM  Will Health Tech Really Make Us Healthier? at Fox Business
11:12AM  Johnson & Johnson Trends Favor Four Stocks at Barrons.com
11:10AM  Correction: Financial Markets story
11:01AM  Strong dollar hits J&J
10:52AM  3 Biotech Stocks Under $10 with Amazing Growth Prospects - Analyst Blog
10:10AM  Stock Market News for April 15, 2015 - Market News
10:03AM  US Stock Market up 0.19% WFC, JPM, and JNJ Beat Estimates
09:29AM  Cramer: Transports could be leaders
09:22AM  Why the Strong Dollar Hurts Investors and What They Should Do About it at Money
08:30AM  More Financials In Focus As Market Scours For Signals at Investor's Business Daily
08:00AM  Pruning Pricey Stocks From Your Portfolio at Kiplinger
01:15AM  Aduro Biotech hits 'unicorn' exit with upsized $119M IPO at bizjournals.com
12:04AM  J&Js Drug Treatment for the Dollar at The Wall Street Journal
12:03AM  [$$] J&Js Profit Falls on Strong Dollar, Weak Medical-Device Sales at The Wall Street Journal
Apr-14-15 07:33PM  Cramer Remix: This company's worth double at CNBC
07:16PM  An Apple Watch A Day & IBM To Keep Doctor Away? at Investor's Business Daily
06:46PM  How Will IBM's New Watson Health Unit Work?
06:23PM  Aduro IPO pricing values drugmaker at $1 bln Reuters
06:12PM  Cramer: Big market positives that can't be ignored at CNBC
05:48PM  J&J Earnings Beat Estimates; Guidance Mixed at Investor's Business Daily
05:46PM  Aduro Biotech IPO priced at $17 per share - underwriter Reuters
05:30PM  Stocks End Mostly Higher After Earnings, Data
05:16PM  Johnson & Johnson and IBM Announce Plans to Collaborate on Advanced Solutions Designed to Transform Healthcare Delivery at noodls
05:08PM  Johnson & Johnson and IBM Announce Plans to Collaborate on Advanced Solutions Designed to Transform Healthcare Delivery at noodls
04:54PM  US stocks mostly higher after rise in oil, mixed earnings
04:20PM  Lackluster Rebound in U.S. Sales Shows Consumers Hesitant
04:16PM  Johnson & Johnson, Pfizer and Zimmer Holdings are Top Stock Picks at TheStreet
04:14PM  Rep. Renee Ellmers Signals Support of Revised Abortion Ban Bill at Bloomberg
03:19PM  Four trades to go before Tuesday's close at CNBC
03:16PM  US stocks mostly higher following mixed profit reports
03:12PM  IBM Watson Health to hire hundreds for new Boston-area HQ at bizjournals.com
03:09PM  J&J cuts full-year forecast due to strong dollar
03:05PM  IBM Launches Watson Health Unit, Buys Health Tech Startups - Analyst Blog
02:58PM  J&J's Drug Treatment for the Dollar at The Wall Street Journal
01:59PM  Johnson And Johnson (JNJ) Earnings Report: Q1 2015 Conference Call Transcript at TheStreet
01:58PM  IBMs Watson Brings Health Care Technology to the Cloud at Bloomberg
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand name; oral care products under the LISTERINE brand name; skin care products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, LUBRIDERM, NEUTROGENA, and RoC brand names; women's health products, such as sanitary pads under the STAYFREE and CAREFREE, and o.b. tampon brand names; wound care products, including adhesive bandages and first aid products under the BAND-AID and NEOSPORIN brand names; and nutritional products comprising no calorie sweetener under the SPLENDA brand name. This segment also offers over-the-counter medicines, including acetaminophen products under the TYLENOL brand name; cold, flu, and allergy products under the SUDAFED brand name; allergy products under the BENADRYL and ZYRTEC brand names; ibuprofen products under the MOTRIN IB brand name; and heartburn products under the PEPCID brand name. The Pharmaceutical segment provides various products in the areas of immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment offers orthopaedic, and trauma and neurological products; general surgery, and biosurgical and energy products; products to treat cardiovascular disease; infection prevention products; diagnostics products; blood glucose monitoring and insulin delivery products; and disposable contact lenses. The company distributes its products to general public, retail outlets and distributors, wholesalers, hospitals, and health care professionals for prescription use in the professional fields by physicians, nurses, hospitals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Fasolo PeterVP, Global Human ResourcesMar 05Option Exercise65.37115,3077,537,619147,895Mar 09 05:14 PM
Fasolo PeterVP, Global Human ResourcesMar 05Sale102.40115,30711,807,86332,588Mar 09 05:14 PM
Stoffels PaulusChief Scientific OfficerFeb 09Option Exercise0.0029,073064,647Feb 11 08:16 PM
Caruso Dominic JVP, Finance; CFOFeb 09Option Exercise0.0031,5370101,324Feb 11 08:16 PM
Fasolo PeterVP, Global Human ResourcesFeb 09Option Exercise0.0020,935042,109Feb 11 08:16 PM
Gorsky AlexChairman, CEOFeb 09Option Exercise0.0042,1120130,173Feb 11 08:17 PM
COSGROVE STEPHEN JCorporate ControllerJan 16Option Exercise0.0011,1080101,402Jan 21 05:48 PM
Ullmann Michael HVP, General CounselJan 16Option Exercise0.008,949075,628Jan 21 05:48 PM
Caruso Dominic JVP, Finance; CFOJan 16Option Exercise0.0012,615074,216Jan 21 05:48 PM
Gorsky AlexChairman, CEOJan 16Option Exercise0.0016,845094,425Jan 21 05:48 PM
Stoffels PaulusChief Scientific OfficerJan 16Option Exercise0.0011,629039,539Jan 21 05:48 PM
Fasolo PeterVP, Global Human ResourcesJan 16Option Exercise0.008,374024,336Jan 21 05:48 PM
PETERSON SANDRA EGroup Worldwide ChairmanDec 17Option Exercise0.0021,689031,210Dec 19 04:37 PM
JOHNSON & JOHNSON10% OwnerNov 12Buy18.0040,000720,0003,077,005Nov 12 03:06 PM
COSGROVE STEPHEN JCorporate ControllerNov 05Option Exercise66.182,490164,78892,784Nov 07 04:49 PM
COSGROVE STEPHEN JCorporate ControllerNov 05Sale108.552,490270,29390,294Nov 07 04:49 PM
CULLEN JAMESDirectorSep 10Sale104.122,446254,6721,489Sep 11 02:19 PM
Caruso Dominic JVP, Finance; CFOAug 21Option Exercise66.1830,0001,985,40091,600Aug 25 04:35 PM
Caruso Dominic JVP, Finance; CFOAug 21Sale104.3030,0003,129,06961,600Aug 25 04:35 PM
COSGROVE STEPHEN JCorporate ControllerMay 05Option Exercise66.1822,0001,455,960112,294May 06 06:10 PM
COSGROVE STEPHEN JCorporate ControllerMay 05Sale100.0522,0002,201,10090,294May 06 06:10 PM
JOHNSON & JOHNSON10% OwnerMay 01Option Exercise5.1672,690375,0801,773,730May 05 02:19 PM